High levels of natural immune suppressor correlate with poor survival in the most common leukemia

by Medical College of Georgia at Augusta UniversityPatients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most lik

Updated on: April 23,2024 18

High levels of natural immune suppressor correlate with poor survival in the most common leukemia

by Medical College of Georgia at Augusta UniversityPatients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most lik

Updated on:April 23,2024 18

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Updated on: August 27,2024 0

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Updated on:August 27,2024 0

New guideline clarifies role of radiation therapy in pancreatic cancer treatment

by American Society for Radiation OncologyAnew clinical guidelinefrom the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to t

Updated on: March 01,2024 13

New guideline clarifies role of radiation therapy in pancreatic cancer treatment

by American Society for Radiation OncologyAnew clinical guidelinefrom the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to t

Updated on:March 01,2024 13

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o

Updated on: August 27,2024 0

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o

Updated on:August 27,2024 0

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on: July 04,2024 4

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on:July 04,2024 4

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024 18

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024 18

How deadly brain cancer evades treatments

by McMaster UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111420McMaster University researcher Sheila Singh and her team have discovered how glio

Updated on: February 03,2024 20

How deadly brain cancer evades treatments

by McMaster UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111420McMaster University researcher Sheila Singh and her team have discovered how glio

Updated on:February 03,2024 20

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on: March 25,2024 9

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on:March 25,2024 9

Drugs to prevent anxiety, stress reactions and inflammation found to reduce risk of metastases after tumor surgery

by Tel Aviv UniversityStress responses and reciprocal stress–cancer interactions. Credit:European Journal of Surgical Oncology(2022). DOI: 10.1016/j.ejso.2022.10.013A short, simple an

Updated on: February 18,2024 17

Drugs to prevent anxiety, stress reactions and inflammation found to reduce risk of metastases after tumor surgery

by Tel Aviv UniversityStress responses and reciprocal stress–cancer interactions. Credit:European Journal of Surgical Oncology(2022). DOI: 10.1016/j.ejso.2022.10.013A short, simple an

Updated on:February 18,2024 17

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on: January 30,2024 12

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on:January 30,2024 12

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024 11

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024 11

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust

Updated on: June 25,2024 5

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust

Updated on:June 25,2024 5